Ireland· IE-PA-PA1353/007/001
Rapibloc 300 mg powder for solution for infusion
A beta blocking agents, selective product containing landiolol hydrochloride, registered in Ireland by Orpha-Devel Handels und Vertriebs GmbH.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Landiolol hydrochloride
- Manufacturer
- Orpha-Devel Handels und Vertriebs GmbH
- Country
- Ireland (IE)
- ATC code
- C07AB
- ATC class
- Beta blocking agents, selective
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA1353/007/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Landiolol hydrochloride in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAPIBLOCAmomed Pharma GmbH, Vídeň
- SwitzerlandRapibloc 300 mg, Pulver zur Herstellung einer InfusionslösungOrPha Swiss GmbH
- BelgiumRunrapiq 300 mgOrpha-Devel Handels und Vertriebs
- United KingdomRapibloc 300mg powder for solution for infusion vialsAOP Orphan Ltd
- NorwayRaplocAmomed Pharma GmbH
- PolandRunrapiqAmomed Pharma GmbH
- SpainRAPIBLOC 300 MG POLVO PARA SOLUCION PARA PERFUSIONOrpha-Devel Handels Und Vertriebs Gmbh
- Japanランジオロール塩酸塩富士製薬工業
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Rapibloc
- Belgium · Runrapiq
- Bulgaria · Рапиблок
- Cyprus · Rapibloc
- Czechia · Rapibloc
- Germany · Rapibloc
- Denmark · Rapibloc
- Estonia · Raploc
- Spain · Rapibloc
- Finland · Rapibloc
- France · Rapibloc
- Greece · Rapibloc
- Croatia · Rapibloc
- Hungary · Rapibloc
- Italy · Landiobloc
- Lithuania · Raploc
- Latvia · Raploc
- Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
- Norway · Raploc
- Poland · Runrapiq
- Portugal · Rapibloc
- Romania · Rapibloc
- Sweden · Rapibloc
- Slovenia · Rapibloc
- Slovakia · Rapibloc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b899eeb8-d397-49dc-9258-9aaf1b96c08f GET /v1/drugs/b899eeb8-d397-49dc-9258-9aaf1b96c08f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"C07AB"
],
"strength": null,
"pa_number": "PA1353/007/001",
"substances": [
"Landiolol hydrochloride"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "09/02/2024",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about landiolol hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.